Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for CNK and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for CNK and 80,000+ other tickers.
See exactly how CNK's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CNK and 80,000+ other tickers.
Cinemark Holdings, Inc., through its various subsidiaries, operates in the business of exhibiting motion pictures. As of June 30, 2022, the company managed a portfolio of 522 movie theaters, encompassing 5,868 screens located across the United States, South America, and Central America. The company was established in 1984 and maintains its principal executive offices in Plano, Texas.
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (“Cinemark”) (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced that it will report its third quarter 2026 operating results and associated executive commentary pre-market and host a webcast to discuss the results on:Tuesday, November 3, 20268:30 a.m. Eastern TimeInterested parties can listen to the call via live webcast.Please access 5-10 minutes before the call:https://event.c.
Cinemark Holdings rated BUY after record 2Q26 EBITDA, with 3Q26 earnings expected to accelerate on a robust summer box office. Box office receipts and premium large-format expansion drive revenue growth and operating leverage, supported by strong film lineups into 2027. CNK's market share gains, premiumization, and healthy balance sheet underpin superior profitability versus AMC, yet shares trade at a 29% EV/EBITDA discount.
Movie theater stocks have become one of the standout trades of the year, with AMC Entertainment (NYSE:AMC) shares leading the group. AMC shares are up 83% year to date (YTD) to $2.86, the largest gain among the biggest U.S.
Heico, Cinemark and Oscar Health are three stocks showing relative strength against the broader market.
CNK's shares rally as record summer box office, premium-format expansion and rising earnings estimates strengthen its appeal as a buying opportunity.